FDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder
RegulatoryapprovedGenglycosPositive
AI Analysis
Summary
Ultragenyx received FDA accelerated approval for Genglycos, its first approved gene therapy for glycogen storage disorder, a rare disease that can cause life-threatening blood sugar crashes.
Outcome Details
FDA granted accelerated approval for Genglycos gene therapy
Importance:9/10
Sentiment:
0.95
FDA approvalgene therapyrare diseaseaccelerated approvalglycogen storage disorder
Related Companies
Read the original article
Published by Endpoints News on August 20, 2026 11:15 AM